Correction to: Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy (BMC Cancer, (2021), 21, 1, (427), 10.1186/s12885-021-08155-2)

Tarek Zaidieh*, James R. Smith, Karen E. Ball, Qian An

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], the authors identified an error in the presentation of Fig. 4. The MT-ND1 subunit residue N382 is incorrect and should be D283. The correct Fig. 4 is supplied below. The original article [1] has been corrected.

Original languageEnglish
Article number528
JournalBMC Cancer
Volume21
Issue number1
DOIs
Publication statusPublished - 10 May 2021

Fingerprint

Dive into the research topics of 'Correction to: Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy (BMC Cancer, (2021), 21, 1, (427), 10.1186/s12885-021-08155-2)'. Together they form a unique fingerprint.

Cite this